One Stop Shop For Reports One Stop Shop For Reports
  • Reports
  • Press Release
  • Statistics
  • About Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • Reports
  • Press Release
  • Statistics
  • About Us
Home ➤ Press Releases ➤ Bright Minds Biosciences Launches Proposed US$100 Million Public Offering
Bright Minds Biosciences Launches Proposed US$100 Million Public Offering
Bright Minds Biosciences Launches Proposed US$100 Million Public Offering
  • Home ➤ Press Releases ➤ Bright Minds Biosciences Launches Proposed US$100 Million Public Offering

Bright Minds Biosciences Launches Proposed US$100 Million Public Offering

Bright Minds Biosciences public offering

Quick Navigation

  • Proceeds Intended for Clinical Trials and Research
  • Four Firms Managing the Offering
  • Offering Uses Existing Shelf Registration
  • About Bright Minds Biosciences

Bright Minds Biosciences Inc. announced on January 6, 2026, that it had launched a public offering targeting aggregate gross proceeds of US$100 million. The biotechnology company intends to use the net proceeds to support clinical trials. Additionally, it will support earlier-stage research and general corporate and working capital needs.

The proposed offering includes common shares. For investors who choose them instead of common shares, pre-funded warrants to purchase common shares are also included. Bright Minds trades on the Canadian Securities Exchange and Nasdaq under the symbol DRUG.

Proceeds Intended for Clinical Trials and Research

Bright Minds plans to use the net proceeds to fund future clinical trials for its drug candidates. These trials include those for absence seizures, DEE, and Prader-Willi syndrome.

The planned uses also include initiating Phase 1 clinical trials for BMB-105. In addition, the company will conduct more research and development on earlier-stage programs. It will also support general corporate and working capital requirements.

Four Firms Managing the Offering

Jefferies, TD Cowen, Piper Sandler & Co., and Cantor are acting as joint book-running managers for the proposed offering.

Bright Minds also intends to grant the underwriters a 30-day option. This allows them to purchase up to an additional 15% of the common shares issued in the offering.

Offering Uses Existing Shelf Registration

The securities are being offered under a shelf registration statement on Form F-3 that the U.S. Securities and Exchange Commission declared effective on September 2, 2025. The offering is being made solely through a prospectus and prospectus supplement forming part of that registration statement.

Bright Minds said a preliminary prospectus supplement and accompanying prospectus would be filed with the SEC. It advised investors to read those documents and its other SEC filings for information about the company and the offering.

The January 6 announcement does not establish that the financing was completed. Bright Minds identified completion of the proposed offering and its expected use of proceeds as forward-looking matters. These are subject to risks and uncertainties.

About Bright Minds Biosciences

Bright Minds Biosciences develops potential treatments for neurological and psychiatric disorders. Its pipeline includes novel compounds targeting key receptors in the brain. The focus is on conditions with high unmet medical need, including epilepsy, depression, and other central nervous system disorders.

The company has developed a platform of highly selective serotonergic agonists targeting different serotonin receptors. This platform supports its portfolio of new chemical entity programs in neurology and psychiatry.

Contact Information

Alex Vasilkevich
Chief Operating Officer
Bright Minds Biosciences Inc.
T: 414-731-6422
E: [email protected]
Website: www.brightmindsbio.com

Related Press Releases

  • TechnoVision: Top 5 Tech Trends to Watch in 2027 By Capgemini
  • AGC Biologics Welcomes Multiple Cell Therapy Projects at Its New Yokohama Facility
  • BlackLine Launches Availability on Anthropic’s Claude Marketplace
  • Mobilicom Announces Participation in Upcoming Industry and Investor Conferences
  • AI Errors Strain Business Finances and Delay Projects Worldwide
  • Neurosterix, an Addex Spin-Out, Closes $105 Million Series B Financing
Latest report from the featured industries
  • Advanced Materials
    Optical Coating Market
    Spray Drying Equipment Market
    Metal Roofing Market
    Stone And Tile Adhesives And Sealants Market
    Armor Materials Market
    PTFE Hoses Market
    Roofing Materials Market
    Acrylic Foam Tape Market
    Oil Shale Market
    Pine-Derived Chemicals Market
  • Aerospace and Defence
    Satellite Launch Systems Market
    Satellite Communication In The Defense Sector Market
    Lyocell Fabric Market
    Bullet Proof Jacket Market
    Rescue Pole Market
    Police Baton Market
    Drone Battery Market
    Gunshot Detection System Market
    Military Electro-optical And Infrared Systems Market
    Multirotor Drone Market
  • Agriculture & Agri Products
    Mooring Systems Market
    Oilseed Processing Market
    Cut Flowers Market
    Cotton Processing Market
    Farm Equipment Rental Market
    Agricultural Variable Rate Technology Market
    Indoor Farming Technology Market
    Essential Oils And Plant Extract For Livestock Market
    Food Vacuum Machine Market
    Ornamental Horticulture Market
  • Apparel | Fashion & Accessories
    3D Printed Jewelry Market
    Cotton (Linter) Pulp Market
    Snow Boots Market
    Merchandise Designing Market
    Volleyball Shoes Market
    Smart Clothing Market
    Workwear Market
    Down Jacket Market 
    Decorated Apparel Market
    Dancewear Market
  • Artificial Intelligence
    AI-Based Defect Detection Software Market
    AI Vision For Manufacturing Market
    AI Training Data Lineage Software Market
    AI Portfolio And Pipeline Management Software Market
    AI In Testing Inspection And Certification Market
    Agentic AI Market
    AI In Telecommunication Market
    AI In Materials Science Market
    AI Data Labeling Market
    AI Data Center Power Consumption Market
✖
Request a Sample Report
We'll get back to you as quickly as possible
CAPTCHA Code

✖
Request a Sample Report
We'll get back to you as quickly as possible
CAPTCHA Code

  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • Our Clients
  • Media Mentions
  • Infographics
  • Statistics and Facts
  • Research Methodology
  • Why Choose Us?
Secured Payment Options
Secured Payment Options

© 2026 Market.Us. All Rights Reserved.